Dr Reddy s Laboratories Limited (RDY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RDY Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Dr Reddy s Laboratories Limited manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
0 0 0 (Mar 31 2025)
Assets
Cash And Cash Equivalents164.00
Cash & Short-term Investments164.00
Notes Receivable, Current13.00
Other Current Assets3,042.00
Total Current Assets3,219.00
Equipment/Property/Plant Net1,236.00
Goodwill net137.00
Intangible Assets0.00
Deferred Tax Assets239.00
Other Assets, Noncurrent1,344.00
Total Assets6,175.00
Liabilities
Accounts Payable0.00
Short-term Debt194.00
Other Liabilities, Current1,593.00
Total Current Liabilities1,787.00
Long-term debt37.00
Total Long-term Debt37.00
Deferred Tax Liabilities, Net LI166.00
Noncurrent Provisions131.00
Total Liabilities2,121.00
Stockholders' Equity
Other Equity4,058.00
Common Stockholder's Equity4,058.00
Total Stockholder's Equity4,054.00
Liabilities & Stockholder's Equity6,175.00
4 historic quarters locked

Sign in to unlock the full Dr Reddy s Laboratories Limited balance sheet history.

About Dr Reddys Laboratories Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20260331)
  • Filed with the SEC: May 29, 2026
  • Source: rdy0899_20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001575872-26-000381

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.